Financhill
Back

Accolade 10K Form

Sell
26

ACCD
Accolade

Last Price:
7.90
Seasonality Move:
-12.94%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ACCD News And Ratings

See the #1 stock for the next 7 days that we like better than ACCD

ACCD Financial Statistics

Sales & Book Value

Annual Sales: $363.14M
Cash Flow: $1.49M
Price / Cash Flow: 0
Annual Sales: $5.65
Price / Book: 1.4

Profitability

EPS (TTM): -1.65480
Net Income (TTM): $-122.73M
Gross Margin: $164.24M
Return on Equity: -26.84%
Return on Assets: -14.17%

Accolade Earnings Forecast

Key Accolade Financial Ratios

  • The Gross Profit Margin over the past 6 years for ACCD is 45.23%.
  • The Selling, General & Administrative Expenses for ACCD have been equal to 49.66% of Gross Profit Margin.
  • The Research & Development expenses have been 27.91% of Revenue.
  • The Interest Expense is -2.36% of Operating Income.
  • The Net Earning history of ACCD is -126.58% of Total Revenues.
  • Per Share Earnings over the last 6 years have been positive in 2 years.

Accolade Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Providers & Services
Sector: Health Care
Current Symbol: ACCD
CUSIP: 00437E
Website: accolade.com

Debt

Debt-to-Equity Ratio: 0.48
Current Ratio: 2.35
Quick Ratio: 2.21

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ACCD Technical Analysis vs Fundamental Analysis

Sell
26
Accolade (ACCD) is a Sell

Is Accolade a Buy or a Sell?

  • Accolade stock is rated a Sell
    The current Accolade [ACCD] share price is $7.89. The Score for ACCD is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.